2nd Quarter - Report
AVENUE SOLUTIONS for EXPRESS SCRIPTS INC
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Post ESI-Medco merger analysis; S. 3187 Food and Drug Administration Safety and Innovation Act - Drug shortages, track and trace, reclassify hydrocodone as Schedule II substance; H.R. 5651, Food and Drug Administration Reform Act of 2012 - Drug shortages, track and trace, reclassify hydrocodone as Schedule II substance
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH MACDONALD BARNETT | — |
| TRACY SPICER | — |
| AMY TEJRAL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.